Round Table Services’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Round Table Services’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-16,080	Closed	-$827K	–	113
2017 Q4	$827K	Sell	16,080 -106,050	-87%	-$5.45M	0.29%	40
2017 Q3	$6.37M	Sell	122,130 -12,027	-9%	-$617K	2.27%	14
2017 Q2	$6.94M	Sell	134,157 -12,192	-8%	-$616K	2.52%	12
2017 Q1	$7.36M	Buy	146,349 +873	+0.6%	+$43.2K	2.65%	13
2016 Q4	$6.86M	Buy	+145,476	New	+$6.9M	2.79%	15

Other funds holding IHE

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

AWA

ARS Wealth Advisors St. Petersburg, Florida $556M AUM 30.03% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Round Table Services's IHE Position: Q1 2018 in Review

Round Table Services sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2018, closing a stake of 16,080 shares — an estimated $827K sold.

Round Table Services first reported a position in IHE in Q4 2016 and held it in 5 quarters. The position peaked at $7.36M in Q1 2017. 101 funds tracked by Wall St. Rank hold IHE as of Q1 2018.

Round Table Services reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2018 after selling out during the quarter.
Round Table Services sold 16,080 iShares US Pharmaceuticals ETF shares in Q1 2018, an estimated $827K.
Round Table Services first reported a position in iShares US Pharmaceuticals ETF in Q4 2016 and held it in 5 quarters.
Round Table Services's iShares US Pharmaceuticals ETF position peaked at $7.36M in Q1 2017.
101 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2018.

Based on Round Table Services's 13F filing for Q1 2018, filed 26 Apr 2018.